Login / Signup
Limitations in the Use of Cystatin C as a Predictor of Major Adverse Cardiovascular Events: Consideration of Non-Renal Factors [Letter].
Muhammad Hamza Shuja
Muhammad Sohaib Khan
Published in:
International journal of general medicine (2023)
Keyphrases
</>
cardiovascular events
coronary artery disease
cardiovascular disease
type diabetes
adverse drug